Drug intelligence / Profile preview

68Ga-DOTA-ECL1i

Development stage
Unknown
Lead developer
Azienda Ospedaliero‑Universitaria di Parma
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Peptides
Administration
Intravenous
01

Overview

68Ga-DOTA-ECL1i is a gallium-68 radiolabeled peptide-based positron emission tomography (PET) imaging tracer. It consists of the extracellular loop 1 inverso (ECL1i) peptide, a 7-D-amino acid allosteric antagonist of C-C chemokine receptor type 2 (CCR2), conjugated to the chelator DOTA and radiolabeled with gallium-68. The tracer is designed to non-invasively detect and track the recruitment of CCR2-expressing inflammatory monocytes and macrophages in vivo. It is primarily being investigated for molecular imaging in myelofibrosis, myocardial infarction, and other inflammatory or fibrotic conditions.

Other names
68Ga-DOTA-ECL1[68Ga]68Ga-DOTA-ECL1i[68Ga]Ga-DOTA-ECL1igallium Ga 68 DOTA-ECL1igallium-68-DOTA-ECL1igallium68-DOTA-ECL1igallium 68-DOTA-ECL1i
02

Targets

CCR2 (Chemokine (C-C motif) Receptor 2)

Beyond the preview

Go deeper on 68Ga-DOTA-ECL1i.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-DOTA-ECL1i.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call